Comparison of different methods of centrifugation for preparation of platelet- rich plasma (PRP)

Similar documents
The Power in You. TM

Discover TruPRP. PRP the way you want it.

Research Study. Comparison of EmCyte GS30-PurePRP II, EmCyte GS60-PurePRP II, Arteriocyte MAGELLAN, Stryker REGENKIT THT, and ECLIPSE PRP

Arthrex Angel TM System. Indication-specific PRP and PRF gel preparations

VIII. Validation Evaluation Comparative Chart Application Fields of PRP Advantages of MiroPRP for skin treatments MicroPRP and Mico-Mesotherapy

RegenACR. autologous cellular regeneration. RegenACR A-PRP treatment. collagen fibers. 1,2 texture and elasticity. 3 volume & strength.

"Release of growth factors in PRP activated with thrombin."

Blood banking applications using the Thermo Scientific Sorvall BP 8 and 16 and Heraeus Cryofuge 8 and 16 centrifuges

EXPERIMENTAL AND THERAPEUTIC MEDICINE 14: , 2017

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups

RegenKit THT. Autologous Platelet Rich Plasma (A-PRP) Reference Guide. Biologics. Concentrated on Healing

Surgical Adhesives in Facial Plastic Surgery

YOUR OWN LIFE

Artist Proof: Clotalyst. Autologous Serum Collection System

Note: The taller 100 x 13 mm tube is not designed to run on the ACL TOP. Plasma after centrifugation of these tubes must be placed in sample cups.

Physiology Unit 3 HEMATOLOGY

Platelet rich plasma (PRP) is under investigation as

Hematology Emergencies: Problems with Platelets

GSI Equine VEGF ELISA Kit-DataSheet

Pre-Analytic Issues in Laboratory Medicine

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

Discussion. Objectives:

Activation of Platelet-Rich Plasma Using Thrombin Receptor Agonist Peptide

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

Correlation of Platelet Concentration in Platelet-rich Plasma to the Extraction Method, Age, Sex, and Platelet Count of the Donor

Section 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)

۱۵ BIOCHEMISTRY & MOLECULAR BIOLOGY

The Story of the Platelet Clump. Wayne Hall MTN Network Laboratory Magee-Womens Research Institute Pittsburgh, PA

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

Human Connective Tissue Growth Factor (CTGF) Elisa Kit

In vitro Human Umbilical Vein Endothelial Cells (HUVEC) Tube-formation Assay. Josephine MY Ko and Maria Li Lung *

The role of autologous fibrin-platelet glue in plastic surgery: A preliminary report

GPS III Platelet Separation System. Leadership through Technology

Upon completion of the Clinical Hematology rotation, the MLS student will be able to:

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

Guide to preparation of liquid biopsies for nucleic acid extraction

Bioreactors in tissue engineering

Official Letter from the DOH

Nori Feline VEGF ELISA Kit-DataSheet

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Quantification of Thrombocyte Growth Factors in Platelet Concentrates Produced by Discontinuous Cell Separation

Blood Product Utilization

The Goals. Maximize RBC Efficacy

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Identification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer. Application Note

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Coagulation in perspective: Blood management. Objectives

Mouse VEGF ELISA. Cat. No: KB2155 Ver3.0 RUO. ELISA for Accurate Quantitation from Cell Culture Supernatant, Serum, Plasma, or Other Bodily Fluids

In Vitro Angiogenesis Assay Kit

The Simple Solution for CBC Testing

WHY USING ACTIVATED PLATELETS AND PATIENT S SERUM IN AESTHETIC MEDICINE..

Regenerative Medicine. Speaker Disclosures. What is regenerative medicine? 6/22/2016

Introduction. Principle

Regenerative Medicine for Joint Disease. Regenerative Medicine for Joint Disease. Regenerative Medicine for Joint Disease

CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS

ISO INTERNATIONAL STANDARD

OVERVIEW OF LABORATORY DIAGNOSTIC TESTING FOR PLATELET DISORDERS

Dry Hematology Analyzer Fast, Simple CBC Analysis Designed for the Point of Care

Iron Deficiency Anemia

Platelet Function Testing Kits (catalogue numbers PSK-001, PSK-002, PSK-003)

Histoacryl A revolution in mesh fixation

Red Cell Transfusion LESSONS FROM TRAUMA

FACTOR XIII DEFICIENCY IN PAKISTAN

For Research Use Only Ver

The Review Section Table (Overview)

Generate Knowledge. STic Expert HIT: for a rapid and confident exclusion of Heparin Induced Thrombocytopenia. Jamal Barsheed

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

Achieving the advantages of Plasma: How to prepare to convert to Plasma, the experience and perspective of a European hospital

engineering microvasculature-on-chip models as research-enabling systems for hemostasis and thrombosis

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

Supplementary Online Content

Category Storage Shelf Life Additional Criteria

Platelet Rich Plasma and Its Use in Androgenetic Alopecia and Alopecia Areata: A Systematic Review

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

Veins Valves prevent engorgement and backflow. Baroreceptor reflex. Veins returning blood

Common Inherited Bleeding Disorders

Quality Parameters of Platelet Concentrate at Kenyatta National Hospital s Blood Transfusion Unit

Sign up to receive ATOTW weekly -

MyBioSource.com. Human VEGF ELISA Kit

-- Laki J. Rousou, MS, MD et. al. -- Boston, Massachusetts. -- Ann Thorac Surg 2009;87:62 70.

Human TGF-beta1 ELISA

a Beckman Coulter Life Sciences: White Paper

Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients

Endothelial Tube Formation Assay (In Vitro Angiogenesis)

NOTE CLAY SEDIMENT-STRUCTURE FORMATION IN AQUEOUS KAOLINITE SUSPENSIONS

Meso BioMatrix Acellular Peritoneum Matrix RECOMMENDED TECHNIQUE GUIDE. Recreating harmonious bodies for a new vision of rebirth.

Information and resources for African Americans living with multiple myeloma and their caregivers

Product Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex

The Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery

COMPONENT NAME COMPONENT # QUANTITY STORAGE SHELF LIFE FORMAT. Do not freeze. Store at 2-8 C. Do not freeze. Store at 2-8 C.

Transcription:

Original Research Article DOI: 10.5958/2394-6792.2016.00099.5 Comparison of different methods of centrifugation for preparation of platelet- rich plasma (PRP) Akanksha Bhatia 1,*, Ramya BS 2, Dayananda S. Biligi 3, Panchakshari Prasanna BK 4 1 PG Student, 2 Assistant Professor, 3 Professor & HOD, Dept. of Pathology, 4 Associate Professor, Dept. of Transfusion Medicine, Bangalore Medical College & Research Institute, Bangalore, Karnataka *Corresponding Author: Email: akanksha26b@gmail.com Abstract Introduction: Platelet- rich plasma (PRP) has wide clinical applications which have been proved by various studies. There are various methods available now-a-days to prepare PRP but no standard protocol determining the time and centrifugation speed is available. This variation in the reported methods may produce samples with different platelet concentrations which may induce different clinical responses. Hence, the aim of the present study was to compare the different methods of centrifugation for preparation of platelet- rich plasma by estimating the platelet concentration in them. Methods: Whole blood was drawn from 50 healthy volunteers into two citrate tubes which were subjected to different centrifugation speed and time. The first tube underwent double spin at 100g (soft spin) and 400g (hard spin) respectively, for 10 minutes; whereas the second tube underwent single spin at 100g for 10 minutes. The platelet counts before and after centrifugations were then compared. Results: Single spin method yielded a platelet concentration factor of 2.19 as compared with the double spin method where, actually the platelet counts reduced (platelet concentration factor= 0.83). Conclusion: From the above findings we conclude that single centrifugation method is better than double centrifugation method in preparation of platelet rich plasma as evidenced by the high platelet concentration factor (2.19). Keywords: PRP, Single spin, Platelet concentration factor Introduction Platelet- rich plasma (PRP) is a preparation of plasma wherein the concentration of platelets is increased. Platelets play a major role in hemostasis and they are also a natural source of various growth factors. Growth factors are stored within the α-granules of platelets, such as the platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), insulin like growth factor (IGF), platelet derived angiogenic factor (PDAF) and transforming growth factor beta (TGF-β). The release of these growth factors depends upon the activation of platelets which can be achieved by a variety of substances like calcium chloride, thrombin and collagen. 1 These above mentioned growth factors help in wound healing and are also involved in regenerative processes like chemotaxis, proliferation, differentiation, and angiogenesis. 2 Various studies have proved the clinical applications and results of PRP in the fields of dermatology, dentistry, oral maxillo-facial surgery, plastic surgery, orthopedics, rheumatology, and also in the treatment of different injuries including chronic wounds and muscle injuries. 3 PRP is also used in platelet aggregation studies in cases of suspected platelet dysfunction. 4 There are many protocols in the current literature which have described the optimal conditions for centrifugation. However, these protocols have been optimized according to numerous variables like the volume and sampling of processed whole blood, number of spins of centrifugation, time period of centrifugation and range of the centrifugal acceleration. There are various methods available now-a-days to prepare PRP but no standard protocol determining the time and speed of centrifugation is available. This variation in the reported methods may produce samples with different platelet concentrations which may induce different clinical responses. Hence, the aim of the present study was to compare the different methods of centrifugation for preparation of platelet- rich plasma (PRP) by estimating the platelet concentration in them. Materials and Methods The study was a prospective study conducted at the Department of Pathology, Bangalore Medical College and Research Institute after obtaining the approval by the Ethics Committee. Whole blood was collected from 50 healthy volunteers, after taking written informed consent. All whole blood samples having normal platelet concentration (1.5-4.5 lakh/cumm) were included in the study. Samples which were clotted or hemolysed, all cases of thrombocytopenia or thrombocytosis, and samples with low hematocrit values were excluded from the study. Methodology: Complete medical details were collected from the volunteer, including past history and history of intake of any drugs. Using aseptic precautions, 10 ml of whole blood was collected from 50 volunteers. After collection of blood, 2 ml of blood was taken in EDTA Indian Journal of Pathology and Oncology, October-December 2016;3(4);535-539 535

(ethylene diamine tetra acetic acid) tube; 3.6 ml of the whole blood was taken in two tubes containing 0.4 ml of 3.8% trisodium citrate each. The two tubes were labeled as first and second tubes. The EDTA sample was run in Coulter LH 780 hematology analyzer to check for hemoglobin, hematocrit and platelet count. The tube labeled as first tube underwent two centrifugation steps under constant temperature conditions: first at 100g for 10 minutes (soft spin) to separate RBCs from remaining whole blood volume. After the first spin, the whole blood was separated into three layers: an upper layer containing platelets and WBC, an intermediate layer which is the buffy coat rich in WBCs and a bottom layer consisting mostly of RBCs. The upper layer plus buffy coat from the first tube were then transferred to an empty tube. The second spin step (hard spin) was then performed on it at 400g for 10 minutes. The upper portion of the volume composed mostly of PPP (platelet- poor plasma) was removed to create the PRP (Platelet- rich plasma). The tube labeled as second tube underwent only single centrifugation step at 100g for 10 minutes under similar temperature conditions and the upper layer composed of platelet rich plasma was separated in an empty tube. Platelet concentrations were then analyzed in both the tubes using Coulter LH 780 hematology analyzer and were compared in both the methods. Statistical analysis: Platelet concentrations before and after centrifugation, were entered in excel sheet and analyzed using T-test. Results Out of the 50 samples collected, 16(32%) were males and 34(68%) were females. The age group ranged from 20-45 years, with a mean of 26.38 years. The platelet count before centrifugation varied from 1.93 to 4.01 lakh/cumm, with a mean of 2.81 lakh/cumm. After centrifugation the Platelet concentration factor (FC pt) was calculated using the formula: FC pt = C pt (after single spin or double spin) C pt (Whole blood) Where, C pt= platelet count After single spin, the mean platelet count was 6.05 lakh/cumm, with a mean platelet concentration factor of 2.19. The maximum platelet count which was obtained after single spin was 8.06 lakh/cumm and maximum platelet concentration factor was 3.15. However, after double spin the mean platelet count dropped to 2.34 lakh/cumm with a mean platelet concentration factor of 0.83. The maximum platelet count which was obtained after double spin was 8.97 lakh/cumm and maximum platelet concentration factor was 2.88. Thus, single spin method yielded higher platelet counts and platelet concentration factor as compared to double spin method (P <0.05). Fig. 1: Distribution of cases according to gender Indian Journal of Pathology and Oncology, October-December 2016;3(4);535-539 536

Table 1: Mean platelet count(in lakh/cumm) Table 2: Mean platelet concentration factor Discussion Platelet- rich plasma (PRP) was first described in 1997 by Whitman et al as a derivative of the fibrin glue. 5 PRP is defined as a fraction of a volume of plasma having a higher platelet concentration than in the peripheral blood. Concentration of platelets and amount of growth factors in the PRP depend on the type of method used. On an average, PRP has about 3-5 times more growth factors than that of peripheral blood. In 2009, Dohan Ehrenfest DM, Rasmusson L, Albrektsson T, proposed a classification wherein four main families of PRP preparation were defined depending upon their cell content and the fibrin architecture. 6 These are: 1. Pure- PRP (P-PRP) or leucocyte-poor PRP: These are preparations without the presence of WBCs and having a low density fibrin network after activation. 2. Leucocyte- and PRP (L-PRP): These preparations have WBCs and have a low density fibrin network after activation. Most of the commercial systems belong to this family only. 3. Pure platelet- rich fibrin (P-PRF)/ leucocyte- poor platelet- rich fibrin preparations: These preparations do not have WBCs but have a high density fibrin network. Such preparations exist only in a strongly activated gel form and cannot be used or injected like traditional fibrin glues. 4. Leucocyte- and platelet- rich fibrin (L-PRF)/ second generation PRP: These are preparations having WBCs along with a high density fibrin network. The yield of platelets in PRP depends mainly on optimal centrifugation conditions. The use of a manual centrifuge which is available in most of the hospitals and laboratories can make it more easily available and ready to use. Therefore, PRP is a cheaper source of growth factors like TGFβ, PDGF, VEGF, IGF-1, etc. and can also stimulate tissue healing. 7 Centrifugation is the most commonly used processes in the separation of liquid-solid or liquidliquid component. It s principle being based on the use of centrifugal force which is much greater than gravity. The separation depends upon the different sizes and density of the particles present in various phases of centrifugation. This separation is caused by the movement of the particles, which is a result of the centrifugal force acting in the radial (outward) Indian Journal of Pathology and Oncology, October-December 2016;3(4);535-539 537

direction, the gravity acting in the downward direction and the frictional force in the opposite direction of the particle motion. This frictional force further depends upon the particle's velocity and the fluid viscosity, as per the Stokes law. All the forces are thus, quickly balanced. Hence, the acting centrifugal force is proportional to the apparent mass and the angular velocity of the particle; and the distance of the particle from the axis of the rotor of the centrifugation machine. The greater this distance, the greater will be the centrifugal force acting and hence, better separation of the components. [3,8,9] In case of whole blood, the platelet concentration factor (FC pt) is determined by the centrifugal force and time, which act by determining the volume of plasma at the upper layer, packing of RBCs at the bottom layer and recovery efficiency of the platelets. 3 Today numerous methods of centrifugation are available. 10 Some authors recommend the single spin method, wherein the whole blood is centrifuged only once. Kahn RA et al proved that a centrifugation of 3731g for 478 ml of whole blood for a time period of 4 minutes was optimal for obtaining the highest platelet concentration in the sample. 11 Marques et al demonstrated that a centrifugal force of 541g for 5 minutes on 60 ml of whole blood was optimal for producing platelet rich plasma (PRP). 7 Anitua E proved that using only a single centrifugation spin and collecting the plasma immediately above the RBC layer, obtained a platelet concentration factor of 2.67. 12 This is in concordance with our study, wherein single centrifugation spin (100g for 10 minutes) showed a platelet concentration factor of 2.19 above the baseline value. However, there have also been studies wherein double spin method of centrifugation has been proved to yield a higher platelet count. Perez AG et al concluded that the double spin centrifugation, that is, processing of 3.5 ml of whole blood at first 100g for 10 minutes, followed by 400g for 10 minutes and withdrawing 2/3rd of the remaining plasma, produced high platelet recovery of nearly 70-80% and also increased the platelet concentration by 5 times. Platelet integrity and viability were also maintained. 3 Similarly, Landesberg R et al obtained a platelet concentration of approximately 3.2 in the PRP samples, by processing 5 ml of whole blood by double spin method; 200g for 10 minutes in each spin. 13 Bausset O, Giraudo L, Veran J, et al found that a centrifugation speed of 130g or 250g for 15 minutes was optimal for double spin centrifugation, by processing 8.5 ml of whole blood in the first spin followed by processing 2.0 ml of plasma in the second spin. This gave a platelet concentration factor of 3.47. However, they also observed in their study that a centrifugation of 400g or 1000g did not increase the platelet concentration factor compared to a 250g centrifugation. 14 They concluded that this could be due to platelet aggregation, which indicates that centrifugation at higher speeds is not suitable for PRP preparation as it can be deleterious for the platelet function. This might be the reason, as to why in our study, the platelet concentration factor dropped significantly to 0.83 as compared to platelet concentration factor of 2.19 after single spin only. Bausset et al 14 also found on electron microscopy that high centrifugation speeds modified the morphology of the platelets considerably in the PRP preparation. At a centrifugation speed of 130g, the platelets displayed a discoid form with less number of pseudopodia. This is consistent with the morphology of a resting platelet. [15,16] At 250g and 400g, the platelets showed greater number of pseudopodia and also show a trend towards centralization of its granules; thereby proving that lower speeds of centrifugation are better suited for preservation of the platelet morphology. 14 Conclusion The utility of platelet-rich plasma is increasing in day-to-day practice. Though there are commercially available systems, but the use of a manual centrifuge can provide a cost effective option. Today there are several techniques available depending upon the time and speed of centrifugation, which has led to confusion regarding its standardization. Our study concluded that a single centrifugation method of 100g for 10 minutes yielded a better platelet count (platelet concentration factor of 2.19 above the baseline value) as compared to a double centrifugation method of 100g and 400g for 10 minutes each (platelet concentration factor of 0.83). However, further research in this area still needs to be done and each laboratory should standardize its protocol for the use of PRP. Acknowledgement The authors deny any conflicts of interest related to this study. References 1. Wang HL, Avila G. Platelet rich plasma: Myth or reality? Eur J Dent. 2007 Oct;1(4):192 194. 2. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg. 1993;165:728 737. 3. Perez AG, Lana JF, Rodrigues AA, Luzo AC, Belangero WD, Santana MH. Relevant aspects of centrifugation step in the preparation of platelet- rich plasma. ISRN Hematol. 2014;2014:176060. 4. Bain B.J., Bates Imelda, Laffan M.A., Lewis S.M. Dacie and Lewis: Practical Hematology; 11 th ed, 2011. 5. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg.1997;55(11):1294-9. 6. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure plateletrich plasma (P-PRP) to leucocyte- and platelet- rich fibrin (L-PRF) Trends Biotechnol. 2009;27:158 67. 7. Marques Fabiana Paulino, Ingham Sheila Jean McNeill, Forgas Andrea, Franciozi Carlos Eduardo da Silveira, Indian Journal of Pathology and Oncology, October-December 2016;3(4);535-539 538

Sasaki Pedro Henrique, Abdalla Rene Jorge. A manual method to obtain platelet- rich plasma. Acta ortop. 2014. 8. Bird B, Steart EW, Lightfoot E. Transport Phenomena. 2nd edition. New York, NY, USA: John Wiley & Sons; 2007. 9. Hunter RJ. Foundations of Colloid Science. New York, NY, USA: Oxford University Press; 2001. 10. Rachita Dhurat, MS Sukesh. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author's Perspective. J Cutan Aesthet Surg. 2014 Oct- Dec;7(4):189 197. 11. Kahn RA, Cossette I, Friedman LI. Optimum centrifugation conditions for the preparation of platelet and plasma products. Transfusion. 1976;16:162 5. 12. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. International Journal of Oral and Maxillofacial Implants. 1999;14(4):529 535. 13. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of plateletrich plasma gel preparation. Journal of Oral and Maxillofacial Surgery. 2000;58(3):297 300. 14. Bausset O, Giraudo L, Veran J, et al. Formulation and storage of platelet-rich plasma homemade product. Biores Open Access. 2012;1(3):115 123. 15. Alonso-Escolano D, Strongin AY, Chung AW, et al. Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol.2004;141:241 252. 16. Radomski A, Jurasz P, Alonso-Escolano D, et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol. 2005;146:882 893. Indian Journal of Pathology and Oncology, October-December 2016;3(4);535-539 539